Medical News

RSS

Researchers present more findings for microbicides, prep at M2010 conference

Researchers on Monday at the International Microbicides Conference in Pittsburgh continued to present data on HIV prevention research, Reuters reports. The news service outlines several prevention methods being researched, including an intravaginal ring that over time releases two antiretrovirals - dapivirine and maraviroc - for up to a month, and a vaginal tablet that time-releases the antiretrovirals dapivirine and DS003 for up to 12 hours.

26 May 2010

Shire announces study results of Vyvanse Capsules CII for treatment of ADHD in adolescents

Shire plc, the global specialty biopharmaceutical company, today announced the results of a study evaluating the safety and efficacy of Vyvanse (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder in adolescents aged 13 to 17 years.

26 May 2010

AHF urges Obama to address growing ADAP crisis

As many states across the nation face budget and funding shortfalls that are crippling their lifesaving AIDS Drug Assistance Programs (ADAPs), AIDS Healthcare Foundation (AHF), the largest global AIDS organization, is urging President Barack Obama to redirect a portion of unspent stimulus funds in the Health and Human Services Department in order to address the growing ADAP crisis.

26 May 2010

Accenture announces enhanced insurance industry solutions

Accenture has unveiled newly enhanced claims and policy administration solutions designed to help property and casualty (P&C) and life insurers focus on operational efficiency and profitable growth by enhancing process automation and multi-channel distribution integration.

26 May 2010

Positive results reported from Phase IIa clinical trial of intranasal oxytocin for CDH

Trigemina, Inc., a Mountain View based privately-held biopharmaceutical company, reports positive results from a time-based interim analysis of its Phase IIa clinical trial in Chronic Daily Headache. The trial is a collaborative effort between Trigemina and Dr. Egilius Spierings of MedVadis Research Corporation located outside of Boston. The study compares intranasal oxytocin with placebo in patients suffering from CDH.

26 May 2010

G7 aid delivers 'impressive results,' commitment falls short of 2005 pledge

According to an annual ONE report, which tracks progress on aid commitments made at the 2005 G8 summit in Gleneagles, Scotland, the G7 - Canada, France, Germany, Italy, Japan, the United Kingdom and the U.S. - is "on track to deliver 61 percent of their combined commitments to sub-Saharan Africa, or $13.7 billion of the $22.6 billion increase they promised," allAfrica.com reports.

26 May 2010

Visually-guided laser-balloon catheter stops abnormal electrical pulses in patients with irregular heartbeats

A new treatment known as a visually-guided laser-balloon catheter successfully interrupted abnormal electrical pulses in patients and pigs with intermittent, irregular heartbeats, in a study reported in Circulation: Arrhythmia and Electrophysiology, a journal of the American Heart Association.

26 May 2010

Study confirms effectiveness of CT for diagnosis of appendicitis

When CT results suggest appendicitis, but a patient's symptoms are inconsistent with the acute condition, physicians should consider a diagnosis of chronic or recurrent appendicitis and surgical treatment, according to a new study published in the online edition and July printed issue of the journal Radiology.

26 May 2010

NEVO Sirolimus-eluting Coronary Stent demonstrates safety and efficacy outcomes at 12 months

At 12 months the NEVO™ Sirolimus-eluting Coronary Stent has continued to demonstrate excellent safety and efficacy outcomes compared to Taxus® Liberte® according to new data presented today from the NEVO™ RES-I clinical trial. These results were presented as a late breaking trial at EuroPCR, the leading medical conference in Europe for physicians specializing in interventional cardiovascular medicine.

26 May 2010

Targeted enrollment in Phase IIb trial for EpiCept NP-1 in CPN attained: EpiCept

EpiCept Corporation today announced that the targeted enrollment in a Phase IIb trial for EpiCept NP-1 in chemotherapy-induced peripheral neuropathy has been attained. The trial is being conducted by National Cancer Institute -funded Community Clinical Oncology Program.

26 May 2010

NIDDK awards Albert Einstein College of Medicine $9.5M for continuation of Diabetes Research and Training Center

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $9.5 million grant for the continuation of its Diabetes Research and Training Center (DRTC). The DRTC was also awarded a $632,000 supplemental grant for equipment and additional pilot and feasibility studies through the American Recovery and Reinvestment Act (ARRA), bringing total NIH support to $10,177,000.

26 May 2010

East African examines 10-year research program to address agriculture, food security, climate change in rural areas

The East African examines the Climate Change, Agriculture and Food Security program, a 10-year research collaboration between the Consultative Group on International Agriculture Research and the Earth System Science Partnership that aims to help rural communities address these issues (Butunyi, 5/24).

26 May 2010

Defect in cellular pathways provides new explanation for earliest stages of craniosynostosis in newborns

University of Rochester Medical Center scientists discovered a defect in cellular pathways that provides a new explanation for the earliest stages of abnormal skull development in newborns, known as craniosynostosis.

26 May 2010

Academic researchers say tour yielded 23 percent increase in patients who got best, cheapest drugs

Reuters reports that 150 academic researchers touring the U.S. to make recommendations on diuretics and best and cheapest practices for blood pressure medicine have reported a 23 percent increase in patients who get the recommended drugs, "twice the increase in the U.S. over the same period."

26 May 2010

$FDA warns on possible fracture risk with proton pump inhibitors use$

FDA warns on possible fracture risk with proton pump inhibitors use

The U.S. Food and Drug Administration today warned consumers and health care professionals about a possible increased risk of fractures of the hip, wrist, and spine with high doses or long-term use of a class of medications called proton pump inhibitors. The product labeling will be changed to describe this possible increased risk.

26 May 2010

RCSI researchers identify biomarker that can predict severity of breast cancer

Researchers from the Royal College of Surgeons in Ireland have identified a biomarker in patient blood which can predict the severity of breast cancer in patients and may enable clinicians to track patients throughout the course of their treatment.

26 May 2010

CMS approves Fresenius Medical Care Chronic Kidney Disease Data Registry

The U.S. Centers for Medicare and Medicaid Services (CMS) approved the Fresenius Medical Care Chronic Kidney Disease Data Registry, supported by its Acumen applications. As a participating registry in CMS's 2010 Physician Quality Reporting Initiative (PQRI), the approval of the nephrology-specific Acumen applications enables participating nephrologists to report quality outcomes directly to the PQRI program.

26 May 2010

Philips Livable Cities Award for improving health and well-being of people living in cities

Royal Philips Electronics today announced the launch of the Philips Livable Cities Award, an initiative designed to generate practical, achievable ideas for improving the health and well-being of people living in cities. Individuals, community or non-governmental groups and businesses are eligible to participate in the Award program that comprises a total prize fund amounting to 125,000 Euros.

26 May 2010

Senate Foreign Relations Committee to mark up $3.5B Haiti reconstruction bill

The Senate Foreign Relations Committee Tuesday is expected to mark up a bill that would "authorize $3.5 billion in reconstruction funds for Haiti over five years" and would also require USAID "to submit a long-term reconstruction plan to Congress as well as mandate the president to appoint a senior policy coordinator for Haiti," The Hill reports (Bogardus, 5/23).

26 May 2010

NASH-induced cirrhosis is greater risk factor for HCC: Cleveland Clinic study

A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

26 May 2010

Medical News

Researchers present more findings for microbicides, prep at M2010 conference

Shire announces study results of Vyvanse Capsules CII for treatment of ADHD in adolescents

AHF urges Obama to address growing ADAP crisis

Accenture announces enhanced insurance industry solutions

Positive results reported from Phase IIa clinical trial of intranasal oxytocin for CDH

G7 aid delivers 'impressive results,' commitment falls short of 2005 pledge

Visually-guided laser-balloon catheter stops abnormal electrical pulses in patients with irregular heartbeats

Study confirms effectiveness of CT for diagnosis of appendicitis

NEVO Sirolimus-eluting Coronary Stent demonstrates safety and efficacy outcomes at 12 months

Targeted enrollment in Phase IIb trial for EpiCept NP-1 in CPN attained: EpiCept

NIDDK awards Albert Einstein College of Medicine $9.5M for continuation of Diabetes Research and Training Center

East African examines 10-year research program to address agriculture, food security, climate change in rural areas

Defect in cellular pathways provides new explanation for earliest stages of craniosynostosis in newborns

Academic researchers say tour yielded 23 percent increase in patients who got best, cheapest drugs

FDA warns on possible fracture risk with proton pump inhibitors use

RCSI researchers identify biomarker that can predict severity of breast cancer

CMS approves Fresenius Medical Care Chronic Kidney Disease Data Registry

Philips Livable Cities Award for improving health and well-being of people living in cities

Senate Foreign Relations Committee to mark up $3.5B Haiti reconstruction bill

NASH-induced cirrhosis is greater risk factor for HCC: Cleveland Clinic study

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News